ArticleCancer reports (Hoboken, N.J.)2022

The rate of estrogen receptor-conversion associated with tumor progression in estrogen receptor-positive breast cancer patients following adjuvant Tamoxifen administration.

Sirus Djahansouzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.